Inhibition of tumor growth in vitro and in vivo by a monoclonal antibody against human chorionic gonadotropin β

Immunology Letters

Volumn 114, Issue 2, 2007, Pages 94-102

  Yu, Ning ^a   Xu, Wei ^a,b   Jiang, Zhenggang ^a   Cao, Qinghua ^a   Chu, Yiwei ^a,b   Xiong, Sidong ^a,b,c  

^a FUDAN UNIVERSITY   (China)

^b E Institutes of Shanghai Universities   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Apoptosis; Cell; Human chorionic gonadotropin; Monoclonal antibody; Tumor

Indexed keywords

CHORIONIC GONADOTROPIN ALPHA SUBUNIT; MONOCLONAL ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL STRAIN HEPG2; CELL STRAIN HL 60; CONTROLLED STUDY; CYTOTOXICITY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; STAINING; SURVIVAL RATE; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, MONOCLONAL; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; TRANSPLANTATION, HETEROLOGOUS;

EID: 36549089445     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2007.09.005     Document Type: Article

References (31)

1. Iles R.K., and Chard T. Immunochemical analysis of the human chorionic gonadotrophin-like material secreted by 'normal' and neoplastic urothelial cells. J Mol Endocrinol 2 (1989) 107-112
2. Iles R.K., Lee C.L., Oliver R.T., and Chard T. Composition of intact hormone and free subunits in the human chorionic gonadotrophin-like material found in serum and urine of patients with carcinoma of the bladder. Clin Endocrinol (Oxf) 33 (1990) 355-364
3. Iles R.K., Purkis P.E., Whitehead P.C., Oliver R.T., Leigh I., and Chard T. Expression of beta human chorionic gonadotrophin by non-trophoblastic non-endocrine 'normal' and malignant epithelial cells. Br J Cancer 61 (1990) 663-666
4. Acevedo H.F., Krichevsky A., Campbell-Acevedo E.A., Galyon J.C., Buffo M.J., and Hartsock R.J. Expression of membrane-associated human chorionic gonadotropin, its subunits, and fragments by cultured human cancer cells. Cancer 69 (1992) 1829-1842
5. Gillott D.J., Iles R.K., and Chard T. The effects of β-human chorionic gonadotrophin on the in vitro growth of bladder cancer cell lines. Br J Cancer 73 (1996) 323-326
6. Acevedo H.F., and Hartsock R.J. Metastatic phenotype correlates with high expression of membrane-associated complete β-human chorionic gonadotropin in vivo. Cancer 78 (1996) 2388-2399
7. Pectasides D., Bafaloucos D., Antoniou F., Gogou L., Economides N., Varthalitis J., et al. TPA, TATI, CEA, AFP, beta-HCG, PSA, SCC, and CA 19-9 for monitoring transitional cell carcinoma of the bladder. Am J Clin Oncol 19 (1996) 271-277
8. Ind T., Iles R., Shepherd J., and Chard T. Serum concentrations of cancer antigen 125, placental alkaline phosphatase, cancer-associated serum antigen and free beta human chorionic gonadotrophin as prognostic markers for epithelial ovarian cancer. Br J Obstet Gynaecol 104 (1997) 1024-1029
9. Carter P.G., Iles R.K., Neven P., Ind T.E., Shepherd J.H., and Chard T. Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance. Br J Cancer 71 (1995) 350-353
10. Sheaff M.T., Martin J.E., and Badenoch D.F. Baithun SI. beta hCG as a prognostic marker in adenocarcinoma of the prostate. J Clin Pathol 49 (1996) 329-332
11. Hotakainen K., Ljungberg B., Paju A., Rasmuson T., Alfthan H., and Stenman U.H. The free beta-subunit of human chorionic gonadotropin as a prognostic factor in renal cell carcinoma. Br J Cancer 86 (2002) 185-189
12. Louhimo J., Alfthan H., Stenman U.H., and Haglund C. Serum HCG beta and CA 72-4 are stronger prognostic factors than CEA CA 19-9 and CA 242 in pancreatic cancer. Oncology 66 (2004) 126-131
13. Szturmowicz M., Slodkowska J., Zych J., Rudzinski P., Sakowicz A., and Rowinska-Zakrzewska E. Frequency and clinical significance of beta-subunit human chorionic gonadotropin expression in non-small cell lung cancer patients. Tumour Biol 20 (1999) 99-104
14. Louhimo J., Carpelan-Holmstrom M., Alfthan H., Stenman U.H., Jarvinen H.J., and Haglund C. Serum HCG beta CA 72-4 and CEA are independent prognostic factors in colorectal cancer. Int J Cancer 101 (2002) 545-548
15. Hedstrom J., Grenman R., Ramsay H., Finne P., Lundin J., Haglund C., et al. Concentration of free hCGbeta subunit in serum as a prognostic marker for squamous-cell carcinoma of the oral cavity and oropharynx. Int J Cancer 84 (1999) 525-528
16. Louhimo J., Kokkola A., Alfthan H., Stenman U.H., and Haglund C. Preoperative hCGbeta and CA 72-4 are prognostic factors in gastric cancer. Int J Cancer 111 (2004) 929-933
17. Span P.N., Manders P., Heuvel J.J., Thomas C.M., Bosch R.R., Beex L.V., et al. Molecular beacon reverse transcription-PCR of human chorionic gonadotropin-beta-3, -5, and -8 mRNAs has prognostic value in breast cancer. Clin Chem 49 (2003) 1074-1080
18. Guan Q.D., Wang Y., Chu Y.W., Wang L.X., Ni J., Guo Q., et al. The distinct effects of three tandem repeats of C3d in the immune responses against tumor-associated antigen hCGβ by DNA immunization. Cancer Immunol Immunother 56 (2007) 875-884
19. Ni Y., Ma K., Ni J., Zheng X.J., Wang Y., and Xiong S.D. A rapid and simple approach to preparation of monoclonal antibody based on DNA immunization. Cell Mol Immunol 1 (2004) 295-299
20. Kohler G., and Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256 (1975) 495-497
21. Glennie M.J., and Johnson P.W. Clinical trials of antibody therapy. Immunol Today 21 (2000) 403-410
22. Ward E.S., and Ghetie V. The effector functions of immunoglobulins: implications for therapy. Ther Immunol 2 (1995) 77-94
23. Clynes R.A., Towers T.L., Presta L.G., and Ravetch J.V. Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets. Nat Med 6 (2000) 443-446
24. Zeng Y., Wu X.X., Fiscella M., Shimada O., Humphreys R., Albert V., et al. Monoclonal antibody to tumor necrosis factor-related apoptosis-inducing ligand receptor 2 (TRAIL-R2) induces apoptosis in primary renal cell carcinoma cells in vitro and inhibits tumor growth in vivo. Int J Oncol 28 (2006) 421-430
25. Durrant L.G., Harding S.J., Green N.H., Buckberry L.D., and Parsons T. A new anticancer glycolipid monoclonal antibody, SC104, which directly induces tumor cell apoptosis. Cancer Res 66 (2006) 5901-5909
26. Ong S.H., Hadari Y.R., Gotoh N., Guy G.R., Schlessinger J., and Lax I. Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins. Proc Natl Acad Sci USA 98 (2001) 6074-6079
27. Shan D., Ledbetter J.A., and Press O.W. Signaling events involved in anti-CD20-induced apoptosis of malignant human B cells. Cancer Immunol Immunother 48 (2000) 673-683
28. Nagata S. Apoptosis by death factor. Cell 88 (1997) 355-365
29. Butler S.A., Ikram M.S., Mathieu S., and Iles R.K. The increase in bladder carcinoma cell population induced by the free beta subunit of human chorionic gonadotrophin is a result of an anti-apoptosis effect and not cell proliferation. Br J Cancer 82 (2000) 1553-1556
30. Butler S.A., and Iles R.K. The free monomeric beta subunit of human chorionic gonadotrophin (hCG β) and the recently identified homodimeric beta-beta subunit (hCG ββ) both have autocrine growth effects. Tumour Biol 25 (2004) 18-23
31. Butler S.A., and Iles R.K. Ectopic human chorionic gonadotropin beta secretion by epithelial tumors and human chorionic gonadotropin β-induced apoptosis in Kaposi's sarcoma: is there a connection?. Clin Cancer Res 9 (2003) 4666-4673